Deutsche Bank’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92M Sell
562,474
-27,556
-5% -$4.24M 0.03% 498
2025
Q4
$103M Buy
590,030
+385,676
+189% +$70.4M 0.03% 461
2025
Q3
$29.4M Buy
204,354
+2,719
+1% +$333K 0.01% 750
2025
Q2
$20.3M Sell
201,635
-108,983
-35% -$8.33M 0.01% 833
2025
Q1
$23.7M Sell
310,618
-178,348
-36% -$13.6M 0.01% 785
2024
Q4
$33.8M Buy
488,966
+212,024
+77% +$15.3M 0.01% 727
2024
Q3
$20.2M Buy
276,942
+20,953
+8% +$1.55M 0.01% 828
2024
Q2
$17.2M Buy
255,989
+1,429
+0.6% +$55.4K 0.01% 854
2024
Q1
$6.91M Buy
254,560
+90,328
+55% +$2.53M ﹤0.01% 1146
2023
Q4
$5.09M Sell
164,232
-1,733
-1% -$44.9K ﹤0.01% 1249
2023
Q3
$4.19M Buy
165,965
+8,387
+5% +$192K ﹤0.01% 1090
2023
Q2
$3.32M Sell
157,578
-72,572
-32% -$1.38M ﹤0.01% 1404
2023
Q1
$3.92M Buy
230,150
+58,115
+34% +$1.13M ﹤0.01% 1340
2022
Q4
$3.44M Buy
172,035
+21,147
+14% +$409K ﹤0.01% 1375
2022
Q3
$3.25M Sell
150,888
-12,316
-8% -$295K ﹤0.01% 1391
2022
Q2
$3.22M Buy
163,204
+6,152
+4% +$129K ﹤0.01% 1502
2022
Q1
$3.69M Sell
157,052
-7,501
-5% -$174K ﹤0.01% 1538
2021
Q4
$4.48M Sell
164,553
-1,999
-1% -$57.2K ﹤0.01% 1495
2021
Q3
$4.59M Sell
166,552
-2,059
-1% -$54K ﹤0.01% 1562
2021
Q2
$4.8M Buy
168,611
+5,446
+3% +$162K ﹤0.01% 1567
2021
Q1
$5.56M Buy
163,165
+8,130
+5% +$311K ﹤0.01% 1485
2020
Q4
$5.16M Sell
155,035
-144,850
-48% -$5.29M ﹤0.01% 1343
2020
Q3
$9.64M Sell
299,885
-174,814
-37% -$5.02M 0.01% 972
2020
Q2
$13.1M Buy
474,699
+106,680
+29% +$2.53M 0.01% 862
2020
Q1
$5.9M Sell
368,019
-43,360
-11% -$1.03M 0.01% 1162
2019
Q4
$9.82M Buy
411,379
+146,346
+55% +$2.98M 0.01% 1093
2019
Q3
$4.67M Buy
265,033
+83,417
+46% +$1.61M ﹤0.01% 1438
2019
Q2
$4.65M Sell
181,616
-9,302
-5% -$259K ﹤0.01% 1863
2019
Q1
$5.55M Sell
190,918
-120,508
-39% -$3.12M ﹤0.01% 1796
2018
Q4
$4.08M Sell
311,426
-80,917
-21% -$1.29M ﹤0.01% 1917
2018
Q3
$7.93M Sell
392,343
-1,575
-0.4% -$35.6K ﹤0.01% 1846
2018
Q2
$9.32M Sell
393,918
-23,100
-6% -$595K ﹤0.01% 1814
2018
Q1
$9.39M Sell
417,018
-13,406
-3% -$353K ﹤0.01% 1669
2017
Q4
$13.4M Sell
430,424
-40,680
-9% -$1.2M 0.01% 1273
2017
Q3
$14.7M Buy
471,104
+234,435
+99% +$4.47M 0.01% 1210
2017
Q2
$4.06M Buy
236,669
+38,265
+19% +$654K ﹤0.01% 2070
2017
Q1
$3.47M Sell
198,404
-277,641
-58% -$4.28M ﹤0.01% 1903
2016
Q4
$6.29M Sell
476,045
-12,764
-3% -$174K 0.01% 1535
2016
Q3
$7.1M Sell
488,809
-40,841
-8% -$511K 0.01% 1515
2016
Q2
$5.22M Buy
529,650
+38,825
+8% +$453K ﹤0.01% 1725
2016
Q1
$6.22M Buy
490,825
+23,392
+5% +$308K ﹤0.01% 1598
2015
Q4
$8.48M Buy
467,433
+8,085
+2% +$142K 0.01% 1432
2015
Q3
$8.53M Buy
459,348
+217,952
+90% +$5.44M 0.01% 1401
2015
Q2
$5.89M Buy
241,396
+46,133
+24% +$1.05M ﹤0.01% 1694
2015
Q1
$4.06M Buy
195,263
+4,252
+2% +$74.9K ﹤0.01% 1936
2014
Q4
$2.95M Sell
191,011
-231,629
-55% -$3.29M ﹤0.01% 2366
2014
Q3
$5.51M Buy
422,640
+206,106
+95% +$3.11M ﹤0.01% 1754
2014
Q2
$4.32M Buy
216,534
+81,279
+60% +$1.2M ﹤0.01% 1923
2014
Q1
$2.57M Buy
135,255
+22,142
+20% +$421K ﹤0.01% 2241
2013
Q4
$1.92M Sell
113,113
-19,756
-15% -$303K ﹤0.01% 2308
2013
Q3
$2.07M Sell
132,869
-171,118
-56% -$2.17M ﹤0.01% 2469
2013
Q2
$3.63M Buy
+303,987
New +$3.11M ﹤0.01% 1816

Other funds holding INSM

Deutsche Bank's INSM Position: Q1 2026 in Review

Deutsche Bank reduced its Insmed (INSM) stake by 4.7% in Q1 2026, selling an estimated $4.24M and leaving 562,474 shares worth $92M. The position accounts for 0.03% of the portfolio, ranked #498.

Deutsche Bank first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Deutsche Bank held 562,474 shares of Insmed worth $92M as of Q1 2026.
  • Deutsche Bank sold 27,556 Insmed shares in Q1 2026, an estimated $4.24M.
  • Insmed made up 0.03% of Deutsche Bank's portfolio in Q1 2026, its #498 holding.
  • Deutsche Bank first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Insmed position peaked at $103M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.